August 24, 2026

Physitrack reports 8% revenue growth and profitable Q2 2026

Physitrack reported Q2 2026 revenue of €3.4 million, up 8% year on year, with adjusted EBITDA of €1.2 million and a 34% margin. The company highlighted continued Lifecare growth, the..

USD/CAD approaches a key technical test as trade tensions return

USD/CAD is testing important technical levels as oversold conditions, improving momentum and renewed US-Canada trade tensions raise the possibility of a rebound...

Meridian Holdings growth outlook supported by Meridianbet momentum and deleveraging, Argus Research

Meridian Holdings Inc. (Nasdaq: MRDN) is continuing to expand its international gaming operations, with Meridianbet taking an increasingly important role in the group’s growth and profitability, according to the latest..

Natural gas outlook strengthens as heat and LNG demand tighten market balance

US natural gas is entering a stronger seasonal setup as heat, slower storage growth and recovering LNG demand improve the market balance...

Gold sets up for a fresh test of higher levels

Gold is building a stronger technical and macroeconomic setup as dollar weakness, US debt concerns and upcoming Federal Reserve signals put higher price levels in focus...

Natural gas rises as heat, LNG demand and supply risks tighten market

Natural gas markets are tightening as heat, recovering LNG demand and European supply risks increase pressure on storage and available supply...

Nuvalent, Inc. (NUVL) Stock Analysis: Evaluating Growth Potential Amidst a Steady Market Position

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, is making waves in the healthcare sector with its innovative approach to cancer treatment. As the company continues..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Is the 17.55% Potential Upside Worth the Risk?

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a prominent player in the biotechnology sector, is renowned for its focus on developing RNA-targeted therapeutics and genetic therapies aimed at treating rare diseases. With..

Inspire Medical Systems (INSP) Stock Analysis: Navigating the Sleep Apnea Market with High Valuation and Mixed Ratings

Inspire Medical Systems, Inc. (NYSE: INSP), a prominent player in the healthcare sector, is gaining attention for its innovative approach to treating obstructive sleep apnea (OSA) with its neurostimulation technology...

Cytokinetics, Incorporated (CYTK) Stock Analysis: Evaluating a Potential 43% Upside in the Biotech Sector

Cytokinetics, Incorporated (NASDAQ: CYTK) presents a compelling case for investors with its focus on pioneering muscle activators and inhibitors aimed at treating debilitating diseases. Despite recent challenges in its financial..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Biotechnology Innovator Seeks 28.67% Upside with Breakthrough Therapies

Rhythm Pharmaceuticals, Inc. (RYTM), a trailblazer in the biotechnology sector, is garnering attention for its innovative approaches to treating rare neuroendocrine diseases. With a market capitalization of $7.57 billion, the..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating the Upside Amidst Market Challenges

Bio-Rad Laboratories, Inc. (NYSE: BIO) is a stalwart in the healthcare sector, specifically within the medical devices industry, with a robust presence across the United States and internationally. With a..

BrightSpring Health Services, I (BTSG): Investor Outlook with a 34% Potential Upside

BrightSpring Health Services, Inc. (NYSE: BTSG) is making waves in the healthcare sector, particularly in the health information services industry. With a substantial market cap of $11.65 billion, the company..

Legend Biotech Corporation (LEGN): Investor Outlook on a Biotech Star with 125.70% Upside Potential

Legend Biotech Corporation (NASDAQ: LEGN) is making waves in the biotechnology sector with its innovative approach to cell therapies, particularly in oncology. This U.S.-headquartered company, founded in 2014, has been..

Glaukos Corporation (GKOS) Investor Outlook: Strong Buy Ratings and Impressive Revenue Growth Set the Stage

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector specializing in ophthalmic pharmaceuticals and medical technology, has caught the attention of investors with its promising growth metrics and..

Teleflex Incorporated (TFX) Stock Analysis: Exploring a 9.88% Potential Upside for Investors

Teleflex Incorporated (NYSE: TFX), a stalwart in the healthcare sector, is making waves in the medical instruments and supplies industry. With a market capitalization of $5.88 billion, this U.S.-based company..

Prestige Consumer Healthcare Inc. (PBH) Investor Outlook: Exploring a 32% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH), known for its expansive portfolio of over-the-counter health and personal care products, presents a compelling opportunity for investors seeking growth in the healthcare sector...

Roivant Sciences Ltd. (ROIV) Stock Analysis: Biotech Innovator with a 15.20% Upside Potential

Roivant Sciences Ltd. (NASDAQ: ROIV) stands out in the biotechnology sector with its innovative approach to drug development and strategic focus on unmet medical needs. While the company, based in..

TransMedics Group, Inc. (TMDX) Stock Analysis: Exploring Growth Potential with a Robust 36.29% ROE

TransMedics Group, Inc. (TMDX) is paving its path in the healthcare sector as a groundbreaking player in the medical devices industry. As a commercial-stage medical technology company, TransMedics specializes in..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Strong Revenue Growth and Robust Pipeline Drive Investor Interest

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is making waves in the biotechnology sector with its innovative enzyme-based drug delivery solutions. With a market capitalization of $12.28 billion, Halozyme stands out as..

Search

Funds

August 24, 2026

Physitrack reports 8% revenue growth and profitable Q2 2026

Physitrack reported Q2 2026 revenue of €3.4 million, up 8% year on year, with adjusted EBITDA of €1.2 million and a 34% margin. The company highlighted continued Lifecare growth, the US launch of its Remote Therapeutic Monitoring platform and further investment in North American expansion...

USD/CAD approaches a key technical test as trade tensions return

USD/CAD is testing important technical levels as oversold conditions, improving momentum and renewed US-Canada trade tensions raise the possibility of a rebound...

Natural gas outlook strengthens as heat and LNG demand tighten market balance

US natural gas is entering a stronger seasonal setup as heat, slower storage growth and recovering LNG demand improve the market balance...

Gold sets up for a fresh test of higher levels

Gold is building a stronger technical and macroeconomic setup as dollar weakness, US debt concerns and upcoming Federal Reserve signals put higher price levels in focus...

Natural gas rises as heat, LNG demand and supply risks tighten market

Natural gas markets are tightening as heat, recovering LNG demand and European supply risks increase pressure on storage and available supply...
Search

Funds

August 24, 2026

FTSE 100

Funds